• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE EXTENSION SETS; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD Q-SYTE EXTENSION SETS; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 385158
Medical Device Problem Code Defective Component (2292)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 12/01/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Initial reporter addr 1: (b)(6).A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event or Problem Description
It was reported that 3 bd q-syte extension sets was clogged.The following information was provided by the initial reporter: qsyte tri extension small bore : have all 3 septums with unable to open with normal needle push.
 
Event or Problem Description
It was reported that 3 bd q-syte extension sets was clogged.The following information was provided by the initial reporter: qsyte tri extension small bore : have all 3 septums with unable to open with normal needle push.
 
Additional Manufacturer Narrative
The following fields were updated due to additional information: d10: device available for eval yes, d10: returned to manufacturer on: 06-feb-2023.H6: investigation summary.Bd received three q-syte assemblies on a tri-extension set from lot 2033442 for evaluation.A review of the device history record was performed for the reported lot and no quality issues were found during production.Our quality engineer disconnected the assembly and visually inspected the returned units.The engineer observed that the disks on each unit were not slit properly.Therefore, based off the visual inspection and testing the engineer was able to verify the reported defect.It was determined that this was a manufacturing defect.The septa are slit during the manufacturing process.If a septum was not slit it may be a result of a broken/missing blade, or mixed product of non-slit septum with slit septum.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD Q-SYTE EXTENSION SETS
Common Device Name
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX 
Manufacturer (Section G)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX  
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key16018975
Report Number9610847-2022-00492
Device Sequence Number17606864
Product Code FPA
UDI-Device Identifier00382903851584
UDI-Public00382903851584
Combination Product (Y/N)N
Initial Reporter CountryIN
PMA/510(K) Number
NA
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 02/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date01/31/2025
Device Catalogue Number385158
Device Lot Number2033442
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/01/2022
Supplement Date Received by Manufacturer02/13/2023
Initial Report FDA Received Date12/20/2022
Supplement Report FDA Received Date03/02/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/21/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-